Overview

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.
Phase:
Phase 2
Details
Lead Sponsor:
American Regent, Inc.
Luitpold Pharmaceuticals
Treatments:
Ferric Oxide, Saccharated
Hematinics